The stock-market hysteria surrounding EntreMed is only the latest in a series of events we list in which an extraordinary quotation dramatically drives up the stock of a company almost overnight. The hype isn't all bad, it turns out.
You may also be interested in...
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.
Italy's Chiesi is looking to take a slice of Poland's consumer healthcare market by acquiring infant supplements specialist Smart Pharma.